# Stability Study Management

## Overview

A **Stability Study Management** application is the quality-control laboratory's system for running product stability studies: it holds each study as a protocol-defined design — product batches placed under defined storage conditions, tested at scheduled time points against acceptance criteria — and carries the study through a scheduled pull-and-test loop until it has produced the reviewed, reported evidence that a product's shelf life and storage-condition claims rest on.

It answers a question no other laboratory system asks in quite this way: *how does this product's quality change over time under defined conditions?* A single stability study runs for months or years, involves many samples sitting in controlled storage, and generates testing work at planned intervals long after the study was designed. Without dedicated management, the program decays into spreadsheets, calendar reminders, and binders.

The defining core is deliberately small:

```text
Stability Study (protocol-defined design)
└── Storage conditions × time-point schedule × tests with acceptance criteria
    └── Scheduled pulls of custody-tracked samples
        └── Testing and results recorded against the study
            └── Review and reporting → the study's stability record
```

Everything else commonly associated with these systems — sample inventory, storage-location tracking, worklists, calendars, trending charts, instrument integrations, and the regulated-laboratory compliance machinery — is standard capability that makes the core practical, not what makes the product a stability study management system.

In the current market this capability is overwhelmingly delivered as a module or workflow inside a laboratory information management system (LIMS), alongside sibling QC workflows such as batch testing and environmental monitoring. That packaging is a market fact, not the definition: the study/protocol/pull structure below is what distinguishes the Type.

## Users & Context

Primary users sit in quality-control laboratories of regulated product manufacturers:

- **Stability coordinator / stability manager** — owns the program: designs studies and protocols, places samples into storage, keeps the pull schedule moving, watches for due and overdue pulls, and assembles study reports. This role exists because a stability program outlives any single test request; someone must carry the multi-year schedule.
- **QC analysts** — execute the work the schedule generates: pull samples from storage, perform the assigned tests, enter results.
- **QA / reviewers** — review and approve results against the study's acceptance criteria; in regulated laboratories they are also the audience for the audit trail and the final study documentation.
- **Laboratory management** — oversees workload, turnaround, and the state of the study portfolio across products.

Typical context: pharmaceutical and biotech QC laboratories operating under GMP expectations, where stability data supports regulatory filings, ongoing product commitments, and annual product reviews. The same structure serves shelf-life studies in adjacent industries — food and beverage is documented in the sampled market — and contract laboratories that run stability programs for manufacturer clients.

The work environment is long-horizon and schedule-driven: a study designed today generates testing work at intervals stretching years out, so the system's value lies in remembering, scheduling, and proving — not in any single day's test.

## Core Model

### The Defining Core

**The stability study.** The unit of record is a persistent, identified study that binds together the elements of the design:

- the **product** and the **batches (lots)** placed under study;
- the **storage conditions** the batches are held under — conditions such as temperature, humidity, and light, defined by the program rather than fixed by the software;
- the **time-point schedule** — the intervals at which samples will be pulled and tested across the study's duration;
- the **tests** to perform at each pull, with their **acceptance criteria** (pass/fail requirements).

A study commonly holds one or more **protocols** — the formal, versioned statements of the design. Products typically offer protocol templates so that a new study for a known product is configured, not reinvented. The protocol is the governing record: pulls, testing, and evaluation are all judged against it.

**The stability sample.** Samples are physical units of the product's batches placed into storage for the study. Each sample carries its identity and context — which batch it came from, which condition and location it sits in, how much remains, when it was retrieved if pulled, and its eventual disposal. Samples persist in the system for the life of the study, which is what makes a multi-year program tractable.

**The pull.** When a time point comes due, the system surfaces the pull: which samples, from which storage locations, for which tests. The pull is the hinge between the design and the work — it converts a row in a schedule into a chain of custody event, assigned work, and eventually results.

**Results and the stability record.** Results are recorded against the study and evaluated against its acceptance criteria. Reviewed and approved results accumulate into the study's stability record — the trended, reportable evidence the study exists to produce.

```text
Product / Batches
   ↓ placed into
Stability Study (protocol: conditions × time points × tests + acceptance criteria)
   ↓ samples held in
Storage (managed locations under defined conditions)
   ↓ time point comes due
Pull (custody-tracked withdrawal)
   ↓ work assigned
Testing → Results recorded against the study
   ↓ reviewed / approved against acceptance criteria
Stability record (trended, reported)
   ↓ repeats at each time point until the study completes
```

### Standard Capabilities

Mature products commonly add the following. They make the core workable at laboratory scale but do not define the Type:

- **Sample inventory and storage-location management** — where each sample sits, in what quantity, under which condition.
- **Chain of custody / full traceability** — a defensible trail for every sample from receipt through storage, pulls, and disposal.
- **Work assignment and worklists** — pulls and tests routed to analysts; role-based dashboards for coordinators, analysts, and managers.
- **Scheduling surfaces** — calendar and plan views of due and upcoming pulls across the study portfolio.
- **Review and approval workflows** — results pass review before they count as evidence.
- **Reporting and trending** — study reports, trend charts across time points, and the documentation packages that regulated reporting consumes.
- **Instrument integration** — result capture from analytical instruments and chromatography data systems rather than manual transcription.
- **Compliance machinery** — audit trails, electronic signatures, and the record-integrity controls expected in GxP laboratories.

### One Structure, Many Implementations

The core model is conceptual; products realize it differently:

```text
Concept:            Protocol-defined study
Implementations:    study containing one or more protocols; protocol templates;
                    study specifications binding sample batches to requirements

Concept:            Scheduled pulls
Implementations:    system-generated pull tasks at due time points;
                    calendar/plan views; manual pull initiation against the schedule

Concept:            Result capture
Implementations:    manual entry with data controls; instrument/CDS connectors;
                    platform-native analysis and charting
```

## How It Works

### Design the study

The coordinator creates the study: selects the product and batches, defines the storage conditions, lays out the time-point schedule, and attaches the tests and their acceptance criteria — commonly starting from a protocol template. The study is approved and becomes the governing record.

### Place samples into storage

Samples of the batches are received into the system and placed into their storage locations under the defined conditions. From this point each sample is tracked — location, quantity, custody — for the duration of the study.

### The schedule drives the work

As time points come due, the system surfaces the pulls that are owed. This is the recurring heartbeat of the application: the coordinator works the due-pull queue, analysts receive assigned work, and nothing depends on someone remembering a date two years after the study started.

### Pull, test, record

An analyst withdraws the pulled samples (custody recorded), performs the assigned tests — in the laboratory or via integrated instruments — and enters results against the study.

### Review and report

Results are reviewed and approved against the acceptance criteria. Approved results join the study's record; trending and reporting surfaces show how each attribute is evolving across time points. The study then waits for its next time point, and the loop repeats until the schedule is exhausted and the study closes with its final report.

### When the normal flow breaks

- **A pull is missed or late** — the schedule makes the gap visible rather than silent.
- **A result fails its acceptance criteria** — the failure is recorded against the study and typically triggers review; in regulated settings it may open a laboratory investigation, which depending on the laboratory is tracked in connected quality-event machinery rather than inside the study itself.
- **The design must change mid-study** — the protocol is the governing record, so changes to the running design are consequential and controlled rather than casual edits.
- **Samples run out or are damaged** — disposal and remaining-quantity tracking keeps the program's material reality visible.

## Interfaces

Described conceptually; exact layouts and names vary by product.

### Study / protocol workspace

The coordinator's home: the list of studies and their state, and the design surface where protocols, conditions, time-point schedules, tests, and acceptance criteria are configured — usually from templates.

- typical information: study identity, product, batches, conditions, schedule, status
- primary actions: create study, configure protocol from template, approve, amend

### Pull schedule / calendar

The program's heartbeat surface: due and upcoming pulls across studies, commonly as calendar or plan views.

- typical information: due time points, samples owed, tests attached, overdue state
- primary actions: generate/confirm pulls, assign work, track completion

### Sample inventory and storage views

Where the material reality of the program lives: samples by study, batch, condition, and storage location, with quantities and custody history.

- typical information: sample identity, batch, location, condition, quantity, status, custody trail
- primary actions: place samples, record movements, record retrieval and disposal

### Worklists and result entry

The analyst's surfaces: assigned pulls and tests, and the screens where results are recorded with data controls.

- typical information: assigned work, method context, result fields, limits
- primary actions: record results, attach instrument data, submit for review

### Review and approval queues

The reviewer's surface: submitted results awaiting evaluation against acceptance criteria, with the audit trail at hand.

- typical information: pending results, criteria, deviations, reviewer identity
- primary actions: approve, reject, request investigation

### Reports and trending

The evidence surface: study reports, trend charts across time points, and the documentation packages consumed by regulatory reporting and product reviews.

- typical information: results by time point and condition, trends, study status
- primary actions: generate reports, chart trends, export

### Administration

Configuration of products, specifications, storage locations, conditions, templates, users, and roles.

## Important Rules / Behaviors

- **The protocol governs.** Pulls, tests, and evaluation are judged against the study's protocol and its acceptance criteria. The design is not advisory: work that drifts from it is visible as a deviation, and changing a running design is a controlled act.
- **Samples are custody-tracked end to end.** From receipt through storage, pulls, and disposal, every sample movement is recorded. In a regulated laboratory the sample trail is as important as the result itself — an unexplainable sample is an indefensible result.
- **Results become evidence only after review.** Recorded results pass review/approval against the acceptance criteria before they count in the study's record. The review step is structural, not optional polish.
- **The schedule outlives the day.** The system's defining behavior is carrying a multi-year schedule forward: due pulls surface when they are owed, and the study's state accumulates across time points. A stability program that depends on memory has already failed.
- **Compliance machinery is load-bearing.** Audit trails, electronic signatures, and record-integrity controls are expected parts of the system in its dominant (GxP) context, because the stability record supports regulatory claims.
- **Longevity shapes data handling.** Studies run for years; samples, results, and the audit trail must remain coherent and retrievable across that horizon, including through product and personnel changes.

## Variants

- **Pharmaceutical / biotech QC** — the dominant form: GxP-regulated studies supporting filings, commitments, and product reviews; the richest compliance machinery.
- **Shelf-life studies in adjacent industries** — food, beverage, and consumer products run the same protocol-conditions-pulls-evaluation structure, usually with lighter regulatory machinery.
- **Contract laboratories / CDMOs** — stability programs run on behalf of manufacturer clients rather than for the laboratory's own products.
- **Packaging variant** — delivered as a LIMS module/workflow (the current market norm, alongside batch testing and environmental monitoring) or, less commonly verified, as a standalone dedicated system.
- **Enterprise posture** — multi-site manufacturers standardize stability programs on one global instance; pre-validated pharma packages and SaaS/on-premises deployment choices segment the market.
- **Integration depth** — from manual result entry to deep instrument/CDS, ERP, and quality-system integration.

A variant remains a variant unless it changes the core model itself; all of the above keep the study–pull–evidence structure intact.

## Related Application Types

| Application Type | Distinction |
|---|---|
| LIMS | the general laboratory sample lifecycle (login → test → result → report); stability study management adds the protocol-designed aging schedule (conditions × time points × acceptance criteria) and is usually delivered inside it |
| Electronic Lab Notebook / ELN | free-form experiment documentation; a stability study is a protocol-driven scheduled program, not a notebook entry — vendors bundle the two but the structures differ |
| Life Sciences QMS | owns deviations, CAPA, and change control; stability results may trigger quality events, but study execution is not QMS work |
| Validation Management | qualifies equipment, processes, and computerized systems; stability establishes how product quality evolves over time — different object, different evidence |
| Chromatography Data System | acquires and processes instrument data; stability management consumes such results through entry or integration |
| Biobank Management | long-term specimen storage with inventory/location tracking, but no protocol-driven pull-test-evaluate loop aimed at shelf-life evidence |
| Laboratory Information System / LIS | clinical, patient-facing testing domain; different users, objects, and rules entirely |
| Environmental Monitoring (QC) | samples the environment for contamination; stability stores product samples under conditions — sibling QC workflows, different objects |
| Clinical Data Management / EDC | human-subject trial data capture; shares only the word "study" |

The most important boundary is with **LIMS**: in the market the two are inseparable (stability ships as a LIMS capability), but the structural test is clean — remove the protocol-designed aging schedule and what remains is generic LIMS sample testing; keep it and a distinct Type with its own object model is present.

## Representative Products

- LabWare LIMS (Stability Study Management module)
- LabVantage LIMS (Pharma package, stability management)
- STARLIMS Quality Manufacturing LIMS (stability workflow)
- Sapio LIMS & ELN (stability monitoring solution)

All four are laboratory-informatics platforms in which stability study management appears as a named, first-class capability; they were sampled across different product philosophies (enterprise configurable, pre-validated pharma package, platform workflow set, no-code science platform) and customer tiers.

## Sources

Research date: **2026-09-09**

- LabWare — LIMS product page (Stability Management feature): https://www.labware.com/lims
- LabWare — Pharmaceutical industry page: https://www.labware.com/industries/pharmaceutical
- LabVantage — Pharma & Biotech industry page: https://www.labvantage.com/industries/pharma-biotech/
- LabVantage — LIMS product page: https://www.labvantage.com/informatics/lims/
- STARLIMS — Quality Manufacturing LIMS page: https://www.starlims.com/rd-quality-manufacturing-informatics-platform/lims/
- Sapio Sciences — Stability Monitoring solution page: https://www.sapiosciences.com/solutions/stability-testing/

> Sourcing limitation: official help-center / user-guide documentation was not reachable from the research environment for any sampled product; evidence comes from official product, industry, and solution pages. Several additional vendors (Veeva, Thermo Fisher SampleManager, Autoscribe) could not be fetched after repeated failures. Accordingly, this document states structural claims with confidence but intentionally avoids precise operational details (numeric schedules, condition sets, chamber-monitoring mechanics, amendment workflows); such specifics remain unasserted. Detailed observations, the cross-product comparison, and the historical market-sample check are recorded in the paired Research Notes.
